The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Prevalence of Chlamydial and Gonococcal Infections Among Young Adults in the United States
Open accessAbstract
CONTEXT: Chlamydial and gonococcal infections are important causes of pelvic inflammatory disease, ectopic pregnancy, and infertility. Although screening for Chlamydia trachomatis is widely recommended among young adult women, little information is available regarding the prevalence of chlamydial and gonococcal infections in the general young adult population. OBJECTIVE: To determine the prevalence of chlamydial and gonococcal infections in a nationally representative sample of young adults living in the United States. DESIGN, SETTING, AND PARTICIPANTS: Cross-sectional analyses of a prospective cohort study of a nationally representative sample of 14,322 young adults aged 18 to 26 years. In-home interviews were conducted across the United States for Wave III of The National Longitudinal Study of Adolescent Health (Add Health) from April 2, 2001, to May 9, 2002. This study sample represented 66.3% of the original 18,924 participants in Wave I of Add Health. First-void urine specimens using ligase chain reaction assay were available for 12,548 (87.6%) of the Wave III participants. MAIN OUTCOME MEASURES: Prevalences of chlamydial and gonococcal infections in the general young adult population, and by age, self-reported race/ethnicity, and geographic region of current residence. RESULTS: Overall prevalence of chlamydial infection was 4.19% (95% confidence interval [CI], 3.48%-4.90%). Women (4.74%; 95% CI, 3.93%-5.71%) were more likely to be infected than men (3.67%; 95% CI, 2.93%-4.58%; prevalence ratio, 1.29; 95% CI, 1.03-1.63). The prevalence of chlamydial infection was highest among black women (13.95%; 95% CI, 11.25%-17.18%) and black men (11.12%; 95% CI, 8.51%-14.42%); lowest prevalences were among Asian men (1.14%; 95% CI, 0.40%-3.21%), white men (1.38%; 95% CI, 0.93%-2.03%), and white women (2.52%; 95% CI, 1.90%-3.34%). Prevalence of chlamydial infection was highest in the south (5.39%; 95% CI, 4.24%-6.83%) and lowest in the northeast (2.39%; 95% CI, 1.56%-3.65%). Overall prevalence of gonorrhea was 0.43% (95% CI, 0.29%-0.63%). Among black men and women, the prevalence was 2.13% (95% CI, 1.46%-3.10%) and among white young adults, 0.10% (95% CI, 0.03%-0.27%). Prevalence of coinfection with both chlamydial and gonococcal infections was 0.030% (95% CI, 0.18%-0.49%). CONCLUSIONS: The prevalence of chlamydial infection is high among young adults in the United States. Substantial racial/ethnic disparities are present in the prevalence of both chlamydial and gonococcal infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Protecting Adolescents From Harm: Findings From the National Longitudinal Study on Adolescent Health
Resnick, M. D. (1997) · JAMA · doi:10.1001/jama.1997.03550100049038 · Cited by 2,846 · cited 1×
“The sampling design for Add Health has been described in detail elsewhere.(18,19) The primary sampling frame for the original Add Health sample included all high schools in the United States with an 11th grade and at least 30 enrollees in the school.”
MethodFleming, D. T., & Wasserheit, J. N. (1999) · Sexually Transmitted Infections · doi:10.1136/sti.75.1.3 · Cited by 2,271 · cited 1×
“Chlamydial and gonococcal infections may increase susceptibility to and transmission of human immunodeficiency virus in both men and women.(5) Because these infections are easy to diagnose and curable with a single dose of oral antibiotics, early detection and treatment are an important component of efforts to reduce…”
BackgroundEstimating the Relative Risk in Cohort Studies and Clinical Trials of Common Outcomes
McNutt, L.-A. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg074 · Cited by 2,096
Sexually transmitted diseases treatment guidelines
Burstein, G. R., & Workowski, K. A. (2003) · Current Opinion in Pediatrics · doi:10.1097/00008480-200308000-00006 · Cited by 2,072
Sexually transmitted disease surveillance.
Schofield, C. B. (1982) · BMJ · doi:10.1136/bmj.284.6318.825-c · Cited by 1,869
1998 Guidelines for Treatment of Sexually Transmitted Diseases: (547782006-001)
(1997) · PsycEXTRA Dataset · doi:10.1037/e547782006-001 · Cited by 621
Genital chlamydial infections: Epidemiology and reproductive sequelae
Cates, W., & Wasserheit, J. N. (1991) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(91)90559-a · Cited by 544
(2002) · PsycEXTRA Dataset · doi:10.1037/e548392006-001 · Cited by 428
The accuracy and efficacy of screening tests for Chlamydia trachomatis: a systematic review
WATSON, E. J., TEMPLETON, A., RUSSELL, I., PAAVONEN, J., MARDH, P.-A., STARY, A., & PEDERSON, B. S. (2002) · Journal of Medical Microbiology · doi:10.1099/0022-1317-51-12-1021 · Cited by 232
A General Model of Sexually Transmitted Disease Epidemiology and Its Implications for Control
Brunham, R. C., & Plummer, F. A. (1990) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30484-9 · Cited by 228
St. Lawrence, J. S., Montaño, D. E., Kasprzyk, D., Phillips, W. R., Armstrong, K., & Leichliter, J. S. (2002) · American Journal of Public Health · doi:10.2105/ajph.92.11.1784 · Cited by 227
Untreated Gonococcal and Chlamydial Infection in a Probability Sample of Adults
Turner, C. F. (2002) · JAMA · doi:10.1001/jama.287.6.726 · Cited by 215
AIDS Epidemiology: A Quantitative Approach.
DeGruttola, V., Brookmeyer, R., & Gail, M. H. (1995) · Journal of the American Statistical Association · doi:10.2307/2291093 · Cited by 187
A population‐based prospective study of Chlamydia trachomatis infection and cervical carcinoma
Wallin, K., Wiklund, F., Luostarinen, T., Ångström, T., Anttila, T., Bergman, F., Hallmans, G., Ikäheimo, I., Koskela, P., Lehtinen, M., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.10639 · Cited by 176
Screening for chlamydial infection
Nelson, H. D., & Helfand, M. (2001) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(01)00253-7 · Cited by 164
Estimates of the Annual Number of Clinically Recognized Pregnancies in the United States, 1981-1991
Saraiya, M., Berg, C. J., Shulman, H., Green, C., & Atrash, H. K. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009747 · Cited by 127
Cook, R. L., Wiesenfeld, H. C., ASHTON, M. R., Krohn, M. A., Zamborsky, T., & Scholle, S. H. (2001) · Journal of Adolescent Health · doi:10.1016/s1054-139x(00)00152-x · Cited by 101
Torkko, K. C., Gershman, K. A., Crane, L. A., Hamman, R. F., & Barón, A. E. (2000) · PEDIATRICS · doi:10.1542/peds.106.3.e32 · Cited by 94
Risk Behaviors, Medical Care, and Chlamydial Infection Among Young Men in the United States
Ku, L. C., Louis, M. S., FARSHY, C. E., Aral, S. O., Turner, C. F., Lindberg, L., & Sonenstein, F. L. (2002) · American Journal of Public Health · doi:10.2105/ajph.92.7.1140 · Cited by 63
Selective screening for chlamydial infection: which criteria to use?
Miller, W. C., Hoffman, I., Owen-O’Dowd, J., McPherson, J. T., Privette, A., Schmitz, J. L., Woodlief, G., & Leone, P. A. (2000) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(99)00146-4 · Cited by 47
Self-citationO’Donnell, L. N., Doval, A. S., Vornfett, R., & O’Donnell, C. R. (1994) · Sexually Transmitted Diseases · doi:10.1097/00007435-199405000-00003 · Cited by 46
American College of Preventive Medicine practice policy statement
Hollblad-Fadiman, K., & Goldman, S. M. (2003) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(02)00636-0 · Cited by 45
Klausner, J. D., McFarland, W., BOLAN, G. A., Hernández, M. T., Molitor, F., Lemp, G. F., Cahoon-Young, B., Morrow, S. A., Ruiz, J., & Young Women's Survey Team (2001) · The Journal of Infectious Diseases · doi:10.1086/319276 · Cited by 44
Screening for Chlamydia in Adolescents and Young Women
Mangione-Smith, R. M., McGlynn, E. A., & Hiatt, L. (2000) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.154.11.1108 · Cited by 42
Cited by
Sexually transmitted infections: challenges ahead
Unemo, M., Bradshaw, C. S., Hocking, J. S., de Vries, H. J. C., Francis, S. C., Mabey, D., Marrazzo, J. M., Sonder, G. J. B., Schwebke, J. R., Hoornenborg, E., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30310-9 · Cited by 751
Kohler, P. K., Manhart, L. E., & Lafferty, W. E. (2008) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2007.08.026 · Cited by 647
“Reported STD diagnoses reflect access to care and symptomatic infection, and most STDs among U.S. teens are asymptomatic [ 24 ].”
BackgroundImmunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine
Brunham, R. C., & Rey-Ladino, J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1551 · Cited by 617
Cohort Profile: The National Longitudinal Study of Adolescent to Adult Health (Add Health)
Harris, K. M., Halpern, C. T., Whitsel, E. A., Hussey, J. M., Killeya-Jones, L. A., Tabor, J., & Dean, S. C. (2019) · International Journal of Epidemiology · doi:10.1093/ije/dyz115 · Cited by 547
Kaestle, C. E. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi095 · Cited by 485
Metadata
- Authors
- Miller, W. C.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2004-05-12
- Volume
- 291
- Issue
- 18
- Pages
- 2229
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2157615258
- Cited by
- 603
- References
- 24
- FWCI
- 46.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.